Take a breather on red-hot Solium Capital, says PI analyst Sangha

Solium Capital (Solium Capital Stock Quote, Chart, News: TSX:SUM) has been on fire for a year, and the company’s share price is beginning to meet targets that once seemed lofty, says PI analyst Pardeep Sangha.

Yesterday, before market, Solium reported its Q2, 2013 results. The company earned $1.34-million on revenue of $15.6-million, a topline that was up 31% over the same period last year. The company beat the consensus revenue estimate of $15.1-million, but its EBITDA of $2.9-million fell short of the street’s expectation of $3.2-million.

Sangha notes that Solium’s revenue growth was driven by the recent acquisitions of pMX, OptionEase, Corporate Focus, andPCAT, but that these additions actually generated a loss in Q2.

For Sangha, the overall impact of the quarter was mixed. He says he is not changing his revenue estimate for fiscal 2013, which is $66.3-million, but is slightly lowering his EBITDA forecast to $14.4-million.

In a research update to clients yesterday, Sangha raised his 12-month target price on Solium from $6.00 to $6.25, but maintained his NEUTRAL rating. Sangha reminds that Solium’s share price, which has raced from $1.60 last July to current highs over six dollars, is now bumping into his target price.

Sangha says he continues to have a positive outlook on Solium Capital’s business, as equity share plans are increasingly complex and the company is well positioned to make an impact on several global markets, after warapping up much of the Canadian market. He thinks Solium will post EBITDA of $19.3-million on revenue of $76-million in fiscal 2014.

At press time, shares of Solium Capital were up 1% to $6.16.

More Cantech Analysts

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: sum
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

3 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

1 day ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

1 day ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

1 day ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago